Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma

2016

AIM To evaluate the inhibitory effects of deferasirox (DFX) against hepatocellular carcinoma (HCC) through basic and clinical studies.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

31

References

24

Citations